腹腔镜胃切除术对局部进展期胃癌合并肌少症患者无复发生存的影响:倾向性评分匹配分析
这项回顾性研究纳入141例局部进展期胃癌合并肌少症患者,经倾向性评分匹配后腹腔镜组与开腹组各50例。中位随访38个月,开腹组无复发生存较差但差异未达统计学显著(HR 1.662,95%CI 0.910-3.034,P=0.098),总生存无差异(P=0.181);多因素分析显示开腹手术是无复发生存的独立预后因素(HR 3.219,95%CI 1.381-7.502,P=0.007),但对总生存不是。
要点
- 局部进展期胃癌合并肌少症患者中,腹腔镜手术组无复发生存优于开腹组。
- 多因素分析显示开腹手术是无复发生存的独立不良预后因素。
- 两组总生存未见显著差异,需更大样本验证。
核心结论
- 与开腹手术相比,腹腔镜胃切除术组无复发生存更好,但差异未达统计学显著。
- 开腹手术是无复发生存的独立预后因素,但不是总生存的独立预后因素。
研究设计与样本
- 回顾性研究,纳入2008年4月至2017年4月因原发性c-stage II或III进展期胃癌行根治性胃切除术且有CT骨骼肌质量记录的患者。
- 共141例肌少症患者,腹腔镜组69例(48.9%),开腹组72例(51.1%)。
- 采用倾向性评分匹配调整背景,匹配后两组各50例,中位随访38个月。
主要发现
- 匹配后开腹组无复发生存较差(HR 1.662,95%CI 0.910-3.034,P=0.098),但差异未达统计学显著。
- 总生存两组无差异(P=0.181)。
- 多因素分析显示开腹手术是无复发生存的独立预后因素(HR 3.219,95%CI 1.381-7.502,P=0.007),但对总生存不是。
临床怎么用
- 对于局部进展期胃癌合并肌少症患者,腹腔镜手术可能改善无复发生存,但需结合患者具体情况个体化选择。
- 开腹手术作为无复发生存的独立不良预后因素,提示在条件允许时可优先考虑腹腔镜入路。
局限性
- 回顾性单中心研究,样本量有限(匹配后每组50例)。
- 无复发生存差异未达统计学显著,结论需谨慎解读。
- 肌少症定义基于骨骼肌质量指数截断值,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent gastric cancer reports have shown that preoperative sarcopenia worsens long-term prognosis after gastrectomy. We investigated the impact of laparoscopic surgery on the long-term prognosis of locally advanced gastric cancer patients with sarcopenia. METHODS: This retrospective study included consecutive patients who underwent radical gastrectomy for primary c-stage II or III advanced gastric cancer, between April 2008 and April 2017, with computed tomography records of skeletal muscle mass. The skeletal muscle mass index was calculated, and sarcopenia was defined when values were below the cut-off. The patients were divided into a laparoscopy group and open group, in which the background was adjusted using propensity score matching; the relapse-free survival and overall survival were compared between them. The prognostic factors for relapse-free survival and overall survival were investigated by multivariate analyses. RESULTS: This study included 141 patients with sarcopenia (laparoscopy group, n = 69 [48.9%]; open group, n = 72 [51.1%]). After matching, there were 50 patients in both groups, with no significant differences in patient background. The median follow-up period was 38 months. Relapse-free survival was worse in the open group (hazard ratio: 1.662, 95% confidence interval: 0.910-3.034; P = 0.098), but there was no difference in the overall survival (P = 0.181). Multivariate analysis concluded that open surgery is an independent prognostic factor of relapse-free survival (hazard ratio: 3.219, 95% confidence interval: 1.381-7.502; P = 0.007) but not of OS. CONCLUSION: Compared with the open surgery group, the laparoscopy group had a better RFS, although the difference was not statistically significant.
引用
- Matsui R, Inaki N, Tsuji T, et al. Impact of laparoscopic gastrectomy on relapse-free survival for locally advanced gastric cancer patients with sarcopenia: a propensity score matching analysis. Surg Endosc. 2021. PMID: 34708295. doi:10.1007/s00464-021-08812-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。